The Latest
“Most Favored Nation” Implementation Expands Dangerous CMMI Authority
Washington, D.C.
CCAGW Urges Ohio Representatives to Oppose HB 276
HB 276 would change how the federal 340B Drug Discount Program operates in Ohio.
CCAGW Urges House of Representatives to Support Overturning Improper Use of E-Rate Funds
S.J. Res.7 blocks the FCC’s E-Rate expansion, which misuses funds, raises taxes, and exceeds the program’s intent.
CCAGW Urges Senate to Oppose the CMMI Models That Use MFN Pricing
Using Center for Medicare and Medicaid Innovation to test Most Favored Nation pricing combines failed agency with bad policy.
CCAGW Urges House of Representatives to Oppose the CMMI Models That Use MFN Pricing
Using Center for Medicare and Medicaid Innovation to test Most Favored Nation pricing combines failed agency with bad policy.
TestimonyTestimony Before the Senate Health, Education, Labor and Pensions Committee on 340B
The 340B Drug Discount Program has drifted from its original mission of helping patients. The reforms promoted by CCAGW and the Senate HELP Committee majority staff report would fix 340B and restore the program to its original mission.











